Market Place
Sourcing Support
All News #Library
Sciences
Antibe Therapeutics Engages Stern IR for Investor Relations Services
07 Aug 2020 //
BUSINESSWIRE
Antibe Therapeutics Engages Stern IR for Investor Relations Services
06 Aug 2020 //
BIOSPACE
Antibe Therapeutics Announces $5 Million Bought Deal Offering
04 Feb 2019 //
BUSINESSWIRE
Antibe Therapeutics` Successfully Completes Part I of Ph 2B Study for ATB-346
28 Nov 2018 //
BUSINESSWIRE
Antibe Therapeutics Receives Approval to Initiate Phase 2B Study for ATB-346
10 Oct 2018 //
BUSINESSWIRE
Antibe Therapeutics Announces Licensing Deal for Lead Drug in South Korea
05 Sep 2018 //
BUSINESSWIRE
Antibe Therapeutics Announces Successful Phase 2B GI Safety Study
20 Mar 2018 //
BIOSPACE
Antibe Therapeutics Announces Completion Of Validation Studies Of ATB-346
21 Dec 2015 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.